Back to Articles
247A2026 Q3GrowthJGAAP

Ai ROBOTICS (247A) FY2026 Q3 Earnings Report

For FY2026 Q3, revenue came to ¥18.5B (+76.1% year on year) and operating income ¥2.5B (+51.5%). The segment drivers and cash flow follow.

Ai ROBOTICS INC.

Raw Materials & Chemicals/Chemicals


Quick View

MetricCurrent PeriodSame Period Previous YearYoY
Revenue¥185.5B¥105.3B+76.1%
Operating Income¥25.3B¥16.7B+51.5%
Ordinary Income¥25.3B¥16.2B+55.9%
Net Income¥17.3B¥11.4B+51.3%
ROE33.9%34.5%-

Executive Summary

While Revenue expanded sharply by 76.1% year on year, Operating Income growth was limited to 51.5%, with profit growth failing to keep pace with the speed of growth being the most notable feature. Revenue was ¥185.5B, Operating Income was ¥25.3B, Ordinary Income was ¥25.3B, and Net Income was ¥17.3B. Although the gross margin remained high at 75.1%, the SG&A ratio reached 61.4%, and the Operating Income margin narrowed by approximately 220bp from an estimated 15.8% in the same period of the previous year to 13.6%. The increase in the SG&A burden accompanying the expansion in business scale indicates a challenge in terms of margins despite higher Revenue and profits.

Factors Affecting Financial Performance

【Revenue】Revenue was ¥185.5B, an increase of 76.1% from ¥105.3B in the same period of the previous year. The rapid expansion in business scale drove Revenue growth. Although detailed segment disclosures are not available, the magnitude of the growth rate suggests that expanding demand for the core business was the primary factor.

【Profit and Loss】Operating Income increased to ¥25.3B (¥16.7B in the same period of the previous year, +51.5%), Ordinary Income increased to ¥25.3B (+55.9%), and Net Income increased to ¥17.3B (+51.3%). However, against Revenue growth of 76.1%, Operating Income growth was limited to 51.5%, while SG&A increased from ¥11.4B to ¥114.0B (SG&A ratio of 61.4%), putting pressure on margins. Non-operating income and expenses were nearly offset by a foreign exchange gain of ¥0.2B and interest expense of ¥0.2B, leaving Ordinary Income at approximately the same level as Operating Income. In conclusion, the Company achieved higher Revenue and profits, but a slowdown in profit growth relative to Revenue growth was observed.

Key Financial Metrics

【Profitability】The Operating Income margin was 13.6% and the Net Income margin was 9.3%. Both maintained a certain level against the backdrop of the high gross margin of 75.1%, but declined from the estimated Operating Income margin of 15.8% in the same period of the previous year.【Cash Quality】Operating Cash Flow has not been disclosed, and the degree to which Net Income of ¥17.3B has been converted into cash cannot be determined. However, the pace of increase in accounts receivable of ¥48.3B and inventories of ¥32.6B may have exceeded the increase in Revenue. Annualized DSO of 71 days, DIO of 193 days, and CCC of 220 days indicate an extension of the working-capital cycle.【Investment Efficiency】ROE was 33.9%, generated by a combination of a Net Income margin of 9.3%, total asset turnover of 1.226x, and financial leverage of 2.97x, with leverage making a significant contribution.【Financial Soundness】The Equity Ratio was 33.7%, down from 47.5% in the previous year. Although apparent short-term liquidity was maintained, with a current ratio of 186.4% and a quick ratio of 144.5%, the short-term debt ratio reached 61.9%, and the refinancing burden associated with interest-bearing debt of ¥56.5B, including short-term borrowings of ¥35.0B, was relatively significant.

Cash Flow Analysis

As the cash flow statement has not been disclosed, funding trends are assessed based on changes in the balance sheet. Cash and deposits were ¥44.1B, up from ¥39.3B in the same period of the previous year. This appears to have resulted from increasing interest-bearing debt of ¥56.5B, including short-term borrowings of ¥35.0B, alongside rising funding needs associated with Revenue expansion. Accounts receivable increased significantly from the previous year to ¥48.3B, while inventories increased to ¥32.6B. Annualized CCC reached 220 days, suggesting that working capital is tying up funds for an extended period as the business grows. The extent to which Net Income of ¥17.3B has actually been collected as cash cannot be directly confirmed because Operating Cash Flow has not been disclosed. However, the pace of increase in accounts receivable and inventories suggests that some delay may be occurring in the conversion of profits into cash.

Earnings Quality

Current-period profits were primarily derived from recurring operating activities, and no special gains or losses or other one-time factors were identified. Non-operating income was limited to a small foreign exchange gain of ¥0.2B, while non-operating expenses were primarily interest expense of ¥0.2B. Accordingly, the difference between Ordinary Income and Operating Income was minimal. From an accrual perspective, however, accounts receivable and inventories increased substantially against Revenue growth of 76.1%, suggesting that cash conversion may be slower relative to profit growth. The estimated effective tax rate was 31.7%. The reduction from Profit Before Tax of ¥25.3B to Net Income of ¥17.3B was within the range of a standard tax burden, and no special tax-related factors were identified.

Earnings Forecast and Guidance

Progress toward the full-year forecast was 66.2% for Revenue, 52.7% for Operating Income, 52.9% for Ordinary Income, and 51.8% for Net Income. All were below the standard Q3 cumulative progress benchmark of 75%. In particular, as progress for the profit-related metrics remained just above 50%, substantial profit accumulation in Q4 will be required to achieve the full-year forecast (Revenue of ¥280.0B, Operating Income of ¥48.0B, and Net Income of ¥33.3B). In Q4, the Company will need to generate more than 47% of its full-year forecast Operating Income, making seasonality and the presence or absence of large projects key determinants of future progress.

Shareholder Returns

The Q2 dividend was ¥0, and the full-year dividend forecast was also ¥0 per share, resulting in a Payout Ratio of 0%. The no-dividend policy has resulted in no cash outflow through dividends, indicating a preference for allocating funds to the refinancing of short-term borrowings, working capital, and growth investments. No disclosure regarding share repurchases was identified.

Risk Factors

  1. Refinancing risk: The short-term debt ratio reached 61.9%, indicating a high degree of dependence on refinancing conditions for interest-bearing debt of ¥56.5B, including short-term borrowings of ¥35.0B. Cash and deposits of ¥44.1B cover short-term debt, but the cushion is limited.

  2. Deterioration in working-capital efficiency: Annualized DSO of 71 days, DIO of 193 days, and CCC of 220 days all exceed general benchmarks, while increases in accounts receivable of ¥48.3B and inventories of ¥32.6B are pressuring funding efficiency. As Operating Cash Flow has not been disclosed, the degree of profit conversion into cash cannot be confirmed.

  3. Risk of expense increases accompanying growth: Against Revenue growth of 76.1%, Operating Income increased by only 51.5%, and the SG&A ratio rose to 61.4%. If personnel, advertising, and other costs associated with business expansion continue to increase, margins may decline further.

Industry Benchmark (For Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

MetricCompanyMedian (IQR)Delta
Operating Income Margin13.6%8.6% (4.3%–12.7%)+5.1pt
Net Income Margin9.3%6.4% (2.8%–10.3%)+2.9pt

Both the Operating Income margin and Net Income margin exceeded the industry median, indicating that profitability is relatively high within the industry.

Growth and Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue Growth Rate (Year on Year)76.1%3.3% (-2.1%–8.9%)+72.8pt

The Revenue growth rate substantially exceeded the industry median, representing an exceptional growth pace within the industry.

Source: Company analysis

Key Points in the Financial Results

  1. Revenue growth of 76.1%, a gross margin of 75.1%, and ROE of 33.9% indicate high growth and profitability even within the industry. However, the Operating Income margin narrowed by approximately 220bp from the previous year, highlighting that the pace of SG&A expansion is affecting the margin trend.

  2. The extension of the working-capital cycle, reflected in annualized CCC of 220 days and DIO of 193 days, indicates rising funding needs accompanying growth. The stabilization of Operating Cash Flow and progress in reducing inventories will be key points in assessing future funding efficiency.

  3. The combination of a short-term debt ratio of 61.9% and a no-dividend policy reflects a capital allocation policy that prioritizes growth investment and financial management stability over shareholder returns. With Q3 progress toward the full-year forecast remaining just above 50%, Q4 performance will be an important factor in evaluating the full year.


This report is an earnings analysis document automatically generated by AI based on XBRL financial results summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available financial results data. Investment decisions should be made at your own responsibility, and after consulting with a professional as necessary.

---End of Report---


AI Financial Analysis

Executive Summary

Ai Robotics delivered strong top-line and earnings growth in FY2026 Q3, although margin compression and materially heavier working-capital requirements temper the quality of the expansion. Revenue increased 76.1% year on year to ¥18.55bn. Operating income rose 51.5% to ¥2.53bn. Ordinary income increased 55.9% to ¥2.53bn. Net income grew 51.3% to ¥1.73bn. The lower rate of operating-profit growth relative to sales indicates reduced operating leverage during the growth phase. Gross margin declined to 75.1% from 78.6% in the prior period, a contraction of approximately 350bp. Operating margin fell to 13.6% from 15.9%, a contraction of approximately 222bp. Net margin declined to 9.3% from 10.8%, a contraction of approximately 153bp. SG&A expenses increased 72.5% to ¥11.40bn, broadly tracking the rapid revenue expansion but remaining a substantial drag on conversion of gross profit into operating profit. Despite margin dilution, the 13.6% operating margin remains in the good range under the stated benchmark. The 45.1% annualized ROE is very high, supported by a 9.3% net margin, 1.635x asset turnover and 2.97x financial leverage. The balance sheet has expanded rapidly, with receivables up 301.1% year on year and inventories up 236.8%, substantially exceeding sales growth. This working-capital build is reflected in elevated annualized DSO of 71 days, DIO of 193 days and a 220-day cash-conversion cycle. Debt has also risen, particularly long-term loans, which increased 239.9% to ¥2.15bn. Liquidity is presently adequate, with a 186.4% current ratio, 144.5% quick ratio and cash equivalent to 1.26x short-term debt. Against full-year guidance, nine-month revenue progress is 66.2%, modestly below the standard 75% pace, while operating-income and net-income progress of 52.7% and 51.8% respectively imply a materially profit-weighted fourth quarter. Achieving guidance requires Q4 revenue of ¥9.45bn, operating income of ¥2.27bn and net income of ¥1.60bn, implying a 24.0% operating margin versus 13.6% cumulatively. The main forward issue is therefore whether management can convert inventory and receivables into cash while delivering the significant Q4 margin recovery embedded in the forecast.

Profitability Analysis

The annualized DuPont ROE of 45.1% decomposes into a 9.3% net profit margin, 1.635x asset turnover and 2.97x financial leverage. Financial leverage is the most consequential factor supporting the headline ROE, as equity funds only 33.7% of total assets and the D/E ratio is 1.97x. The operating business remains highly profitable at the gross-profit level, with a 75.1% gross margin, but this is 350bp below the prior-period 78.6%. Operating margin declined 222bp to 13.6%, because sales growth of 76.1% was not fully translated into operating-income growth of 51.5%. SG&A rose approximately 72.5% year on year to ¥11.40bn, indicating that growth-related selling, marketing, personnel or administrative costs absorbed much of the gross-profit expansion. Net margin fell 153bp to 9.3%, additionally affected by a 31.7% effective tax rate. The tax burden factor of 0.683 is moderately below the 0.70 normal benchmark, while the interest burden of 1.000 and interest coverage of 143.08x indicate that current interest costs are immaterial relative to EBIT. Non-operating items are small: net non-operating expense was approximately ¥0.02bn, with ¥0.24bn of FX gains offset by interest and other expenses. Consequently, reported profit is principally operating in nature rather than dependent on non-operating gains. The key sustainability question is whether gross-margin and operating-margin pressure reflects temporary investment for rapid customer acquisition and scale-up, or a more structural change in product mix, promotional intensity or procurement costs.

Growth Assessment

Growth is exceptional on the reported cumulative basis, with revenue up 76.1%, operating income up 51.5% and net income up 51.3% year on year. The disparity between revenue growth and profit growth confirms that the current expansion is margin-dilutive rather than fully scale-accretive. Receivables rose to ¥4.83bn from ¥1.21bn and inventories to ¥3.26bn from ¥0.97bn, suggesting that a significant portion of growth has required upfront working-capital deployment. Inventory growth of 236.8% is especially notable relative to sales growth and creates exposure to sell-through, markdowns and product obsolescence. Revenue progress against full-year guidance is 66.2%, 8.8 percentage points below the standard Q3 progress rate of 75%. Operating-income progress is 52.7%, 22.3 percentage points below the standard pace, and net-income progress is 51.8%, 23.2 percentage points below. The guidance is thus dependent on an unusually strong Q4, including an implied operating margin of 24.0%. That implied margin is well above both the cumulative 13.6% level and the prior-period cumulative operating margin of 15.9%. The forecast may be achievable if sales seasonality, product launches, or high-margin inventory conversion are concentrated in Q4, but the required earnings acceleration raises execution sensitivity. FX gains of ¥0.24bn, equal to approximately 9.3% of operating income, are favorable but not central to the ordinary-profit result.

Financial Health

Liquidity is sound at the reporting date. Current assets of ¥14.49bn cover current liabilities of ¥7.77bn by 1.86x, and the quick ratio is also healthy at 1.45x. Working capital totals ¥6.71bn. Cash and deposits of ¥4.41bn represent 29.1% of total assets and cover 1.26x short-term debt. However, funding risk is elevated by the maturity profile: 61.9% of interest-bearing debt is short term, above the 40% refinancing-risk alert threshold. Short-term loans total ¥3.50bn, while current portions of long-term loans and bonds add further near-term repayment obligations. Current liabilities are nevertheless covered by current assets, so there is no current maturity mismatch at the balance-sheet level. Interest-bearing loans total ¥5.65bn, and the D/E ratio is 1.97x, narrowly below the 2.0x aggressive-financing warning threshold. Debt/capital is 52.6%, which is elevated relative to the 40% investment-grade benchmark but below the 60% concern threshold. Long-term loans increased ¥1.52bn, or 239.9% year on year, consistent with increased external financing for business expansion and working capital. Equity increased 54.1% to ¥5.10bn, mainly through retained earnings, which rose 102.7% to ¥3.41bn. Capital adequacy nevertheless declined to 33.7% from 47.5%, showing that liabilities and assets expanded faster than equity. Construction in progress was ¥0.83bn, or 23.9% of PPE, exceeding the 20% alert threshold; this indicates an active investment pipeline but also raises execution, timing and cost-overrun risk until assets are commissioned.

Notable B/S Changes

Accounts receivable: +¥3.63bn (+301.1%) to ¥4.83bn - growth materially exceeded revenue growth and is consistent with the elevated 71-day annualized DSO; collection and credit risk require monitoring. Inventories: +¥2.29bn (+236.8%) to ¥3.26bn - inventory expansion substantially outpaced sales growth, contributing to 193 annualized inventory days and elevated obsolescence/markdown risk. Long-term loans: +¥1.52bn (+239.9%) to ¥2.15bn - increased debt funding supports expansion but raises leverage and refinancing sensitivity. Accounts payable: +¥0.48bn (+185.6%) to ¥0.74bn - supplier credit expanded, but not enough to offset the much larger receivables and inventory build. Retained earnings: +¥1.73bn (+102.7%) to ¥3.41bn - retained profitability has strengthened equity, though not enough to prevent a decline in capital adequacy. PPE: +¥0.93bn (+36.6%) to ¥0.35bn - investment is increasing, with construction in progress of ¥0.83bn representing 23.9% of PPE and requiring monitoring for completion and returns.

Cash Flow Quality

Cash-flow conversion cannot be quantified from the reported data because operating, investing and financing cash-flow totals are not provided. Balance-sheet movements nevertheless indicate a potentially substantial cash absorption from working capital. Accounts receivable increased by ¥3.63bn year on year, far faster than the 76.1% increase in revenue. Annualized DSO of 71 days exceeds the 60-day alert threshold, indicating slower collection or a greater share of credit-based sales. Inventories increased by ¥2.29bn year on year, and annualized DIO of 193 days significantly exceeds both the 90-day warning threshold and the 60-day manufacturing benchmark. The resulting annualized cash-conversion cycle of 220 days exceeds the 120-day warning level. Trade payables increased by ¥0.48bn to ¥0.74bn, but this supplier financing increase is small relative to the rise in receivables and inventory. These trends create a risk that accounting earnings are not converting into operating cash at the same pace. Inventory consists principally of merchandise of ¥3.26bn, with supplies of ¥0.42bn, making demand forecasting, product-cycle management and markdown discipline important. Cash and deposits increased modestly to ¥4.41bn despite the material expansion in working-capital balances, reinforcing the importance of monitoring future operating cash generation and debt reliance.

Dividend Sustainability

The company reported no Q2 dividend and forecasts a full-year DPS of ¥0. Accordingly, there is no current cash-dividend obligation and no dividend payout ratio. Retained earnings increased to ¥3.41bn from ¥1.68bn, indicating that earnings are being retained to support growth and balance-sheet funding. The absence of dividends preserves financial flexibility while receivables, inventories, capital investment and debt are increasing rapidly. This capital-allocation stance is prudent given the 220-day cash-conversion cycle and the high proportion of short-term debt. Future dividend capacity will depend less on reported earnings alone than on demonstrated conversion of inventory and receivables into operating cash flow, maintenance of liquidity, and progress in reducing refinancing dependence.

Risk Assessment

Business risks include Working-capital execution risk is high: annualized DSO of 71 days, DIO of 193 days and a 220-day cash-conversion cycle indicate that sales growth is tied to substantial customer-credit and inventory funding., Inventory risk is material because inventories increased 236.8% year on year to ¥3.26bn, well ahead of revenue growth; weak sell-through, demand shifts, discounting or product obsolescence could pressure gross margin and cash generation., Guidance execution risk is elevated: achieving the full-year plan requires Q4 operating income of ¥2.27bn and an implied 24.0% operating margin, far above the 13.6% cumulative margin., Margin risk remains relevant because gross, operating and net margins each declined year on year despite rapid growth; sustained promotional, acquisition or logistics costs could prevent the expected Q4 recovery., For a consumer-product and inventory-led business, product lifecycle, demand forecasting, channel inventory and supplier availability are industry-specific risks that can directly affect sell-through, stock write-downs and gross margin., FX exposure is present: FY2026 Q3 included ¥0.24bn of FX gains, approximately 9.3% of operating income, so currency movements can affect ordinary income even though they are not the principal earnings driver..

Financial risks include Refinancing risk is elevated because 61.9% of debt is short term, above the 40% quality-alert threshold., Leverage is meaningful, with D/E of 1.97x, debt/capital of 52.6% and financial leverage of 2.97x; the high ROE therefore incorporates balance-sheet risk., Long-term loans increased 239.9% year on year to ¥2.15bn, while capital adequacy fell to 33.7% from 47.5%, indicating debt-funded balance-sheet expansion., Construction in progress represents 23.9% of PPE, above the 20% alert threshold; delays or cost overruns could defer expected operating benefits..

Key concerns include The core concern is whether rapidly expanding receivables and inventories can be converted into cash without write-downs, extended collection periods or additional borrowings., The second key concern is the large gap between cumulative profitability and the profit level required in Q4 to meet full-year guidance., The 45.1% annualized ROE should not be viewed solely as operating efficiency because leverage materially amplifies returns., Interest servicing is currently strong, with 143.08x interest coverage, but future credit risk depends on sustaining earnings and reducing the need for short-term refinancing..

Investment Implications

Key takeaways include Revenue and profits are growing rapidly, but profit growth is lagging revenue and margins have compressed., The company retains a strong gross-margin profile, yet a 350bp gross-margin decline and 222bp operating-margin decline warrant scrutiny., Liquidity ratios are healthy, but the balance sheet is becoming more leveraged and more dependent on short-term debt., Working-capital metrics are the most significant financial quality issue, particularly 193 inventory days and a 220-day cash-conversion cycle., Full-year guidance requires a substantial Q4 acceleration in both sales and profitability..

Metrics to watch include Quarterly inventory balance, inventory days and any inventory valuation losses or markdown pressure, Accounts receivable growth, annualized DSO and collection performance, Operating cash flow relative to net income and free-cash-flow generation, Short-term debt balance, refinancing terms, D/E ratio and capital adequacy, Gross margin, SG&A-to-sales ratio and progress toward the implied Q4 24.0% operating margin, Construction-in-progress completion, capital expenditure and the operational return on newly commissioned assets.

Regarding relative positioning, The company combines above-benchmark profitability, including a 13.6% operating margin and 45.1% annualized ROE, with weaker-than-benchmark working-capital efficiency and elevated leverage. Its financial profile is therefore growth-oriented rather than conservative: liquidity is currently adequate, but valuation of operating performance should focus on cash conversion, inventory discipline and the credibility of the back-end-loaded earnings plan.